Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04906863 · ClinicalTrials.gov registry record

Genetic Studies of Early-onset Dementia

A clinical trial of Dementia, Early Onset, sponsored by Columbia University.

Recruiting
Registry status
1,000
Enrollment target
1
Study location

NCT04906863: Recruiting study of Dementia, Early Onset, sponsored by Columbia University.

NCT04906863 is a study of Dementia, Early Onset that is actively recruiting participants, run by Columbia University. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04906863, a study of Dementia, Early Onset, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.

Primary Outcome

Genetic factors will be measured through genome-wide genotyping arrays and/or whole-genome sequencing, and then correlated with Alzheimer disease and related phenotypes, such as cognitive impairment, functional impairment, and relevant biomarkers.

Conditions Studied

Interventions

  • GENETIC Blood draw
  • OTHER Neurocognitive testing
  • OTHER Medical questionnaire

Study Locations (1)

New York

  • Columbia University Irving Medical Center - New York

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2016-09-14
Est. Completion 2028-04-30
Columbia University

958 total trials

What NCT04906863 shows while recruiting

NCT04906863 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Dementia, Early Onset appearing as the primary indexed condition, and to 3 interventions - of which Blood draw is the first listed.

NCT04906863 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04906863 about?

NCT04906863 is a clinical study titled "Genetic Studies of Early-onset Dementia". The aim of this study is to identify genetic factors that contribute to risk and progression of early-onset dementia (loss of memory function before the age of 70 years) across all ethnic groups, including Alzheimer's Disease, mild cognitive impairment and other dementias.

What is the current status of trial NCT04906863?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2016-09-14. Estimated completion is 2028-04-30.

What conditions does trial NCT04906863 study?

This clinical trial studies the following conditions: Dementia, Early Onset.

What interventions are being tested in trial NCT04906863?

The interventions under investigation include: Blood draw (GENETIC), Neurocognitive testing (OTHER), Medical questionnaire (OTHER).

Who is sponsoring clinical trial NCT04906863?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04906863 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT02828592 · started 2016-09-09 · Phase 2

    Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia

  • NCT02932176 · started 2016-09-07

    Machine Learning for Handheld Vascular Studies

  • NCT03380195 · started 2016-09-01 · NA

    Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness

  • NCT02897063 · started 2016-09 · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

Source: ClinicalTrials.gov NCT04906863, the US trial registry maintained by the National Library of Medicine. NCT04906863 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.